Standard therapeutic protocol

DRUG3 trials

Sponsors

Alonso Vera Torres, Nanfang Hospital, Southern Medical University, IRCCS Centro Neurolesi Bonino Pulejo

Conditions

Active MalignanciesCovid19Development Language DisorderIschemic Stroke, Acute

Phase 2

Cri Analog PG1 Effectiveness and Safety in Covid-19

WithdrawnNCT04536363

Alonso Vera TorresCovid19

Start: 2020-12-03End: 2020-12-03Updated: 2023-09-15

Phase 4

A Trial of Edaravone Dexborneol in Acute Ischemic Stroke With Active Malignancy

Not yet recruitingNCT07091994

Nanfang Hospital, Southern Medical UniversityActive Malignancies, Ischemic Stroke, Acute

Start: 2026-08-01End: 2026-12-31Target: 144Updated: 2026-04-16

Unknown Phase

Promoting Motivation and Linguage in Developmental Language Disorder Through Interaction With the Humanoid Social Robot

Enrolling by invitationNCT07426328

IRCCS Centro Neurolesi Bonino PulejoDevelopment Language Disorder

Start: 2025-02-01End: 2026-04-01Target: 50Updated: 2026-02-23